In just a couple of days, the oncology
community of physicians, scientists and researchers,
allied medical professionals, advocates, the
pharmaceutical and biotechnology industry, and others,
will gather in Chicago, for the 49th Annual Meeting of
the American Society of Clinical Oncology (ASCO).
This annual meeting will bring together 30,000 cancer
specialists from around the world, presenting
educational sessions, posters, and as many as 5000
abstracts, sharing data and the results of clinical
trials and research on a global scale. It is at
such meetings where shared discoveries will often lead
to new standards and practice-changing patient care,
innovation, and hope.
ASCO 2013 marks the 15th Year that Vital Options
has been privileged to be amongst selected media
reporting from the Annual Meeting. In 1998, when
the Annual Meeting last took place in Los Angeles,
The Group Room?, was the first radio
show allowed to broadcast live from the ASCO
floor. That was a true milestone for Vital Options
and demonstrated the commitment of ASCO on behalf of
patient outreach and partnership. Please visit
ASCO’s oncologist-approved cancer information website
at Cancer.net.
The Group Room and other Vital
Options programs are now in a video format, but we
continue reporting on the latest scientific findings,
clinical advances, human interest stories, and the
progress being made by cancer advocates throughout the
country.
Advocacy In Action? at ASCO
has expanded to three topics, the Genomics of
Metastatic Cancer, Palliative Care, and
the latest Lung Cancer Treatment Guidelines &
Molecular Testing. This show allows leaders
of the advocate community to engage in discussions with
academic oncologists, exploring how advocacy and science
intertwine, and taking on issues that really matter from
the patient’s point of view.
This year’s ASCO meeting theme is Building
Bridges to Conquer Cancer. We hope to bring
you back some great videos showing how the bridges are
truly being connected through our growing knowledge and
understanding of molecular biology and cancer, and the
importance of integrative oncology care!
Until soon
then.
Best of
wishes,
A
THREE-PART ADVOCATE
ROUNDTABLE
VIDEO SERIES
AT ASCO
2013
Vital Options
International presents Advocacy In Action,
bringing together cancer advocacy leadership to
address:
Genomics Of
Metastatic Cancer
Palliative
Care
Lung
Cancer Treatment Guidelines & Molecular
Testing
Sunday,
June 2 | 11:00am – 1:30pm
Hyatt
McCormick Place
Room
CLARK AB
11:00-11:30:
Meet & Greet Reception with
Snacks
11:30-11:50:
Genomics of Metastatic Cancer
11:55-12:50:
Palliative Care
12:55-1:30:
Lung Cancer Treatment Guidelines & Molecular
Testing
Genomics
of Metastatic Cancer
Heinz-Josef
Lenz, MD, FACP, Associate Director for Clinical
Research and Co-Leader of the GI Oncology Program, USC
Norris Comprehensive Cancer Center
Shirley
Mertz, President, Metastatic Breast Cancer
Network
Palliative
Care
Jamie
H. Von Roenn, MD – Professor of Medicine,
Division of Hematology/Oncology; Feinberg School of
Medicine, Northwestern University; Robert H. Lurie
Comprehensive Cancer Center; Chair, ASCO thematic
meeting—Palliative Care in Oncology; Chair of the ASCO
Leadership Development Program, Chair of the ASCO
Professional Development Committee; Co-Chair of the
AACR-ASCO Clinical Trials Workshop, and Chair of the
2014, ASCO thematic meeting—Palliative Care in
Oncology
Linda
House, RN, BSN, MSM – Executive Vice President
of External Affairs, Cancer Support Community, and
C-Change (for which she Co-Chairs the Guidance
Subcommittee of the C-Change Assuring Value in Cancer
Care Advisory Committee)
Helen
Miller, LCSW – CEO, CancerCare
Shirley
Mertz, President, Metastatic Breast Cancer
Network
Lung
Cancer Treatment Guidelines & Molecular
Testing
David
R. Spigel, MD – Director, Lung Cancer Research
Program at Sarah Cannon Research Institute and a Medical
Oncologist at Tennessee Oncology, PLLC, Nashville,
TN
Ming
S. Tsao, MD, FRCPC – Princess Margaret Cancer
Centre, Toronto, Canada
Andrea
Stern Ferris – President, LUNGevity
Kim
Norris – Founder/President, Lung Cancer
Foundation of America
Regina
Vidaver, PhD – Executive Director, National
Lung Cancer Partnership
Support for The Group
Room and Advocacy In Action at ASCO 2013 is made
possible in part by:
These
interviews were filmed with doctors around the
globe at the European Society for Medical
Oncology (ESMO) 2012 Annual Meeting in
Vienna.
Each
doctor was asked the following question:
Data
in advanced cancer shows that palliative care
given concurrently with standard anti-cancer
treatment; extends life and reduces
hospitalizations. How should this evidence
from the Temel Study be integrated in oncology
care today?
These
are their answers.
The Group Room and
Advocacy In Action video content can now be
found on the new Avva Ask
App!
Avva Ask? is the
essential app for cancer patients. It’s a voice
recorder and health information organizer that’s
simple, free, and easy to use. Record voice memos
or entire visits with your doctor quickly and
easily, and play them back at any time. For each
treatment or other health event you enter into the
app – whether it’s a biopsy, chemotherapy, or
other treatment – you can access educational
materials, see tips from other users on managing
side effects, and make a list of questions for
your doctor about that treatment based on our
suggestions, and note down answers, whether typed
or audio recorded.
Avva Ask? is the
second mobile app developed by Avva, founded by
Stanford University graduate students with the
guidance of physicians at the Stanford Cancer
Institute. The app does not require you to sign up
for an account or submit any personal information,
and all information you save is secure and
anonymous.To learn more or download the
application, click here.
Coming Up Next …
American Society of Clinical
Oncology (ASCO), European
Multidisciplinary Cancer Congress (EMCC), World
Conference on Lung Cancer (WCLC), San Antonio Breast Cancer Symposium
(SABCS) and American Society of
Hematology (ASH).12-month
corporate memberships to help
support all of our content year-round, as well as
individual conference sponsorships are
available.
For more
information on the memberships/conference
packages, production services and advocacy
relations please contact, Terry
Wilcox at twilcox@vitaloptions.org.
For more
information on sponsorships, corporate relations,
and other programming opportunities, please
contact, Selma Schimmel
at
sschimmel@vitaloptions.org.
About Vital Options
International
Founded in 1983 as the first
organization for young adults with cancer, Vital
Options is now a cancer communications
organization, serving all age groups and cancer
types with a mission to facilitate a global cancer
dialogue. Headquartered in Southern
California, its European program is based in
France at the American Hospital of Paris, with
production partners at Radio Marsden, the Royal
Marsden Hospital, London, UK.
VITAL
OPTIONS INTERNATIONAL
Advocacy In Action? at
ASCO
2013
MAY 2013
Worldwide View On Palliative Care
Video
Dear Silvia,
Selma
Schimmel Founder &
CEO
In just a couple of days, the oncology
community of physicians, scientists and researchers,
allied medical professionals, advocates, the
pharmaceutical and biotechnology industry, and others,
will gather in Chicago, for the 49th Annual Meeting of
the American Society of Clinical Oncology (ASCO).
This annual meeting will bring together 30,000 cancer
specialists from around the world, presenting
educational sessions, posters, and as many as 5000
abstracts, sharing data and the results of clinical
trials and research on a global scale. It is at
such meetings where shared discoveries will often lead
to new standards and practice-changing patient care,
innovation, and hope.
ASCO 2013 marks the 15th Year that Vital Options
has been privileged to be amongst selected media
reporting from the Annual Meeting. In 1998, when
the Annual Meeting last took place in Los Angeles,
The Group Room?, was the first radio
show allowed to broadcast live from the ASCO
floor. That was a true milestone for Vital Options
and demonstrated the commitment of ASCO on behalf of
patient outreach and partnership. Please visit
ASCO’s oncologist-approved cancer information website
at Cancer.net.
The Group Room and other Vital
Options programs are now in a video format, but we
continue reporting on the latest scientific findings,
clinical advances, human interest stories, and the
progress being made by cancer advocates throughout the
country.
Advocacy In Action? at ASCO
has expanded to three topics, the Genomics of
Metastatic Cancer, Palliative Care, and
the latest Lung Cancer Treatment Guidelines &
Molecular Testing. This show allows leaders
of the advocate community to engage in discussions with
academic oncologists, exploring how advocacy and science
intertwine, and taking on issues that really matter from
the patient’s point of view.
This year’s ASCO meeting theme is Building
Bridges to Conquer Cancer. We hope to bring
you back some great videos showing how the bridges are
truly being connected through our growing knowledge and
understanding of molecular biology and cancer, and the
importance of integrative oncology care!
Until soon
then.
Best of
wishes,
A
THREE-PART ADVOCATE
ROUNDTABLE
VIDEO SERIES
AT ASCO
2013
Vital Options
International presents Advocacy In Action,
bringing together cancer advocacy leadership to
address:
Genomics Of
Metastatic Cancer
Palliative
Care
Lung
Cancer Treatment Guidelines & Molecular
Testing
Sunday,
June 2 | 11:00am – 1:30pm
Hyatt
McCormick Place
Room
CLARK AB
11:00-11:30:
Meet & Greet Reception with
Snacks
11:30-11:50:
Genomics of Metastatic Cancer
11:55-12:50:
Palliative Care
12:55-1:30:
Lung Cancer Treatment Guidelines & Molecular
Testing
Genomics
of Metastatic Cancer
Heinz-Josef
Lenz, MD, FACP, Associate Director for Clinical
Research and Co-Leader of the GI Oncology Program, USC
Norris Comprehensive Cancer Center
Shirley
Mertz, President, Metastatic Breast Cancer
Network
Palliative
Care
Jamie
H. Von Roenn, MD – Professor of Medicine,
Division of Hematology/Oncology; Feinberg School of
Medicine, Northwestern University; Robert H. Lurie
Comprehensive Cancer Center; Chair, ASCO thematic
meeting—Palliative Care in Oncology; Chair of the ASCO
Leadership Development Program, Chair of the ASCO
Professional Development Committee; Co-Chair of the
AACR-ASCO Clinical Trials Workshop, and Chair of the
2014, ASCO thematic meeting—Palliative Care in
Oncology
Linda
House, RN, BSN, MSM – Executive Vice President
of External Affairs, Cancer Support Community, and
C-Change (for which she Co-Chairs the Guidance
Subcommittee of the C-Change Assuring Value in Cancer
Care Advisory Committee)
Helen
Miller, LCSW – CEO, CancerCare
Shirley
Mertz, President, Metastatic Breast Cancer
Network
Lung
Cancer Treatment Guidelines & Molecular
Testing
David
R. Spigel, MD – Director, Lung Cancer Research
Program at Sarah Cannon Research Institute and a Medical
Oncologist at Tennessee Oncology, PLLC, Nashville,
TN
Ming
S. Tsao, MD, FRCPC – Princess Margaret Cancer
Centre, Toronto, Canada
Andrea
Stern Ferris – President, LUNGevity
Kim
Norris – Founder/President, Lung Cancer
Foundation of America
Regina
Vidaver, PhD – Executive Director, National
Lung Cancer Partnership
Support for The Group
Room and Advocacy In Action at ASCO 2013 is made
possible in part by:
These
interviews were filmed with doctors around the
globe at the European Society for Medical
Oncology (ESMO) 2012 Annual Meeting in
Vienna.
Each
doctor was asked the following question:
Data
in advanced cancer shows that palliative care
given concurrently with standard anti-cancer
treatment; extends life and reduces
hospitalizations. How should this evidence
from the Temel Study be integrated in oncology
care today?
These
are their answers.
The Group Room and
Advocacy In Action video content can now be
found on the new Avva Ask
App!
Avva Ask? is the
essential app for cancer patients. It’s a voice
recorder and health information organizer that’s
simple, free, and easy to use. Record voice memos
or entire visits with your doctor quickly and
easily, and play them back at any time. For each
treatment or other health event you enter into the
app – whether it’s a biopsy, chemotherapy, or
other treatment – you can access educational
materials, see tips from other users on managing
side effects, and make a list of questions for
your doctor about that treatment based on our
suggestions, and note down answers, whether typed
or audio recorded.
Avva Ask? is the
second mobile app developed by Avva, founded by
Stanford University graduate students with the
guidance of physicians at the Stanford Cancer
Institute. The app does not require you to sign up
for an account or submit any personal information,
and all information you save is secure and
anonymous.To learn more or download the
application, click here.
Coming Up Next …
American Society of Clinical
Oncology (ASCO), European
Multidisciplinary Cancer Congress (EMCC), World
Conference on Lung Cancer (WCLC), San Antonio Breast Cancer Symposium
(SABCS) and American Society of
Hematology (ASH).12-month
corporate memberships to help
support all of our content year-round, as well as
individual conference sponsorships are
available.
For more
information on the memberships/conference
packages, production services and advocacy
relations please contact, Terry
Wilcox at twilcox@vitaloptions.org.
For more
information on sponsorships, corporate relations,
and other programming opportunities, please
contact, Selma Schimmel
at
sschimmel@vitaloptions.org.
About Vital Options
International
Founded in 1983 as the first
organization for young adults with cancer, Vital
Options is now a cancer communications
organization, serving all age groups and cancer
types with a mission to facilitate a global cancer
dialogue. Headquartered in Southern
California, its European program is based in
France at the American Hospital of Paris, with
production partners at Radio Marsden, the Royal
Marsden Hospital, London, UK.
